Trial intelligence / Profile preview

Optimal dose of protamine for heparin reversal in open heart surgery

TCTR20151118005Recruiting

Sponsor
Faculty of Medicine, Prince of Songkhla University
Start
Nov 2015
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Trial of protamine in heparin-induced thrombocytopenia (HIT), sponsored by Faculty of Medicine, Prince of Songkhla University. Started Nov 2015; status: recruiting.

02

Drugs

protamine
03

Conditions

heparin-induced thrombocytopenia (HIT)

Beyond the preview

Go deeper on TCTR20151118005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20151118005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call